한글목차

세계의 합성 면역학 시장 규모는 2034년에 걸쳐 CAGR 25.6%로 성장할 것으로 예측됩니다.

생명 공학 진보가 시장 성장을 견인 :

합성 생물학, 유전자 편집 및 면역 요법의 기술의 발전은 특히 합성 면역의 신흥 분야에서 의료 전망에 혁명을 일으키고 있습니다. 합성 생물학 기술은 연구자들에게 생물학적 분자의 설계와 구축에 대한 전례없는 제어를 제공하여 특정 치료 요구에 맞는 새로운 합성 분자의 창출을 가능하게합니다. 바이오 의약품은 업계를 선도했으며 2023년에는 시장 수익의 41% 이상 점유율을 보였습니다. 생물제제는 FDA에 의한 신약 승인수로 기존의 의약품을 상회하고 있습니다. 합성 항체, 사이토카인, 수용체를 공학적으로 설계함으로써 연구자들은 면역세포, 경로, 질병 항원을 정확하게 표적화하고 효능과 특이성을 높일 수 있습니다. CRISPR-Cas9와 같은 유전자 편집 기술을 통해 연구자들은 T 세포와 같은 면역 세포의 유전자코드를 변경하고 질병 세포를 인식하고 제거하는 능력을 높일 수 있습니다. 이러한 표적화된 접근법은 오프타겟 효과를 최소화하고 면역요법의 전반적인 효과를 향상시킬 수 있습니다.

합성 면역이 높은 개발 비용이 산업 성장을 방해할 가능성 :

합성 면역요법과 진단 도구의 개발에는 조기 발견부터 임상시험, 약사 승인에 이르기까지 여러 단계에 걸친 R&D에 많은 투자가 필요합니다. 주요 비용 요인 중 하나는 원하는 치료 및 진단 특성을 가진 합성 분자를 설계, 설계 및 제조하는 최첨단 기술과 전문 지식의 필요성입니다. 여기에는 고급 실험 장비, 계산 도구, 합성 생물학, 유전자 편집, 면역학에 숙련된 전문 인력에 대한 투자가 포함됩니다. 또한, 합성 면역요법 및 진단제의 안전성 및 효능을 평가하기 위한 임상시험의 실시는 R&D 비용의 상당 부분을 차지합니다. 임상시험에는 환자 모집, 데이터 수집 및 분석, 적절한 임상 기준(GCP) 준수 등 광범위한 리소스가 필요합니다.

세계의 합성 면역(Synthetic Immunology) 시장을 조사했으며, 시장 개요/시장 성장에 미치는 영향요인 및 시장 기회 분석/법 규제 환경/시장 규모 추이 및 예측/각종 구분 및 지역·주요 국가별 세부 사항 분석/경쟁 구도/주요 기업 프로파일 등을 정리했습니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
• 영향 분석
  • 시장 견인 요인
  • 시장 성장 억제요인
  • 시장 기회
• 공급망 분석
• 규제 프레임워크
• 신흥 시장과 메가 트렌드
• Porter's Five Forces 분석
• PEST 분석

제4장 합성 면역학 시장 분석 : 유형별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추이 및 예측
• 합성 항체
• 합성 백신
• 합성 보조제
• 합성 면역조절제
• 기타
  • 시장 규모 추이 및 예측 : 지역별
  • 시장 점유율 : 지역별

제5장 합성 면역학 시장 분석 : 용도별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추이 및 예측
• 감염증
• 자가면역질환
• 암
• 알레르기
• 기타
  • 시장 규모 추이 및 예측 : 지역별
  • 시장 점유율 : 지역별

제6장 합성 면역학 시장 분석 : 최종 사용자별

• 주요 조사 결과
• 시장 매력도 지수
• 시장 규모 추이 및 예측
• 병원
• 클리닉
• 연구기관
• 기타
  • 시장 규모 추이 및 예측 : 지역별
  • 시장 점유율 : 지역별

제7장 합성 면역학 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추이 및 예측

제8장 북미의 합성 면역학 시장 분석

제9장 유럽의 합성 면역학 시장 분석

제10장 아시아 태평양의 합성 면역학 시장 분석

제11장 남미의 합성 면역학 시장 분석

제12장 중동 및 아프리카의 합성 면역학 시장 분석

제13장 기업 프로파일

• 경쟁 구도
• 전략적 전망
• ADC Therapeutics
• BioNTech SE
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• Synthego
• GenScript Biotech Corporation
• Ginkgo Bioworks
• Inscripta, Inc.
• Moderna, Inc.
• Synlogic Therapeutics
• Evonetix Ltd.
• Sherlock Biosciences
• Mission Therapeutics
• Camena Bioscience
• Mammoth Biosciences

제14장 총론·제안

• Visiongain의 총론
• 시장 진출기업에 대한 제안

영문목차

The global Synthetic Immunology market is projected to grow at a CAGR of 25.6% by 2034

The Synthetic Immunology Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Biotechnology Driving Market Growth

Technological advancements in synthetic biology, gene editing, and immunotherapy have revolutionized the landscape of healthcare, particularly in the emerging field of synthetic immunology. Synthetic biology techniques provide researchers with unprecedented control over the design and construction of biological molecules, allowing for the creation of novel synthetic molecules tailored to specific therapeutic needs. Biopharmaceuticals are leading the charge within the industry, capturing over 41% of the market revenue in 2023. Biologics are surpassing traditional drugs in terms of new drug approvals by the FDA. By engineering synthetic antibodies, cytokines, and receptors, researchers can precisely target immune cells, pathways, or disease antigens with enhanced efficacy and specificity. Gene editing technologies, such as CRISPR-Cas9, enable researchers to modify the genetic code of immune cells, such as T cells, to enhance their ability to recognize and eliminate diseased cells. This targeted approach minimizes off-target effects and improves the overall effectiveness of immunotherapies.

High Development Costs of Synthetic Immunology Likely to Hamper Industry Growth

The development of synthetic immunotherapy and diagnostic tools entails significant investment in research and development (R&D) across multiple stages, from early discovery to clinical testing and regulatory approval. One of the primary cost drivers is the need for cutting-edge technology and expertise to design, engineer, and produce synthetic molecules with the desired therapeutic or diagnostic properties. This includes investment in sophisticated laboratory equipment, computational tools, and specialized personnel skilled in synthetic biology, gene editing, and immunology. Moreover, conducting clinical trials to evaluate the safety and efficacy of synthetic immunotherapy and diagnostic products represents a substantial portion of R&D costs. Clinical trials require extensive resources, including patient recruitment, data collection and analysis, and compliance with regulatory standards for Good Clinical Practice (GCP).

What Questions Should You Ask before Buying a Market Research Report?

How is the synthetic immunology market evolving?

What is driving and restraining the synthetic immunology market?

How will each synthetic immunology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each synthetic immunology submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading synthetic immunology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the synthetic immunology projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of synthetic immunology projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the synthetic immunology market?

Where is the synthetic immunology market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the synthetic immunology market today, and over the next 10 years:

Our 257-page report provides 102 tables and 148 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Type

Synthetic Antibodies

Synthetic Vaccines

Synthetic Adjuvants

Synthetic Immunomodulators

Others

Application

Infectious Diseases

Autoimmune Diseases

Cancer

Allergies

Others

End-users

Hospitals

Clinics

Research Institutes

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Singapore

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Synthetic Immunology Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

ADC Therapeutics

BioNTech SE

Camena Bioscience

CRISPR Therapeutics AG

Editas Medicine, Inc.

Evonetix Ltd.

GenScript Biotech Corporation

Ginkgo Bioworks

Inscripta, Inc.

Mammoth Biosciences

Mission Therapeutics

Moderna, Inc.

Sherlock Biosciences

Synlogic Therapeutics

Synthego

Overall world revenue for Synthetic Immunology Market, 2024 to 2034 in terms of value the market will surpass US$19.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Synthetic Immunology Market, 2024 to 2034 report help you?

In summary, our 250+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Synthetic Immunology Market, 2024 to 2034, with forecasts for type, application, end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 24 key national markets - See forecasts for the Synthetic Immunology Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Synthetic Immunology Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Synthetic Immunology Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Synthetic Immunology Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
• 3.3 Impact Analysis
  • 3.3.1 Market Driving Factors
    • 3.3.1.1 Advancements in Biotechnology
    • 3.3.1.2 Increasing Prevalence of Chronic Diseases
    • 3.3.1.3 Rapid Growth in Cancer Immunotherapy
  • 3.3.2 Market Restraining Factors
    • 3.3.2.1 High Development Costs of Synthetic Immunology
    • 3.3.2.2 Challenges in Regulatory Process
    • 3.3.2.3 Ethical Considerations of Synthetic Immunology
  • 3.3.3 Market Opportunities
    • 3.3.3.1 Growing Demand of Personalized Medicine
    • 3.3.3.2 Emerging Therapeutic Areas
    • 3.3.3.3 Growing Synthetic Vaccine Development
• 3.4 Supply Chain Analysis
• 3.5 Regulatory Framework
• 3.6 Emerging Markets and Megatrends
• 3.7 Porter's Five Forces Analysis
  • 3.7.1 Bargaining Power of Suppliers
  • 3.7.2 Bargaining Power of Buyers
  • 3.7.3 Competitive Rivalry
  • 3.7.4 Threat of Substitutes
  • 3.7.5 Threat of New Entrants
• 3.8 PEST Analysis

4 Synthetic Immunology Market Analysis by Type

• 4.1 Key Findings
• 4.2 Type Segment: Market Attractiveness Index
• 4.3 Synthetic Immunology Market Size Estimation and Forecast by Type
• 4.4 Synthetic Antibodies
  • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 Synthetic Vaccines
  • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 Synthetic Adjuvants
  • 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 Synthetic Immunomodulators
  • 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)
• 4.8 Others
  • 4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.8.2 Market Share by Region, 2024 & 2034 (%)

5 Synthetic Immunology Market Analysis by Application

• 5.1 Key Findings
• 5.2 Application Segment: Market Attractiveness Index
• 5.3 Synthetic Immunology Market Size Estimation and Forecast by Application
• 5.4 Infectious Diseases
  • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Autoimmune Diseases
  • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 Cancer
  • 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)
• 5.7 Allergies
  • 5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.7.2 Market Share by Region, 2024 & 2034 (%)
• 5.8 Others
  • 5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Synthetic Immunology Market Analysis by End-User

• 6.1 Key Findings
• 6.2 End-users Segment: Market Attractiveness Index
• 6.3 Synthetic Immunology Market Size Estimation and Forecast by End-User
• 6.4 Hospitals
  • 6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.4.2 Market Share by Region, 2024 & 2034 (%)
• 6.5 Clinics
  • 6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.5.2 Market Share by Region, 2024 & 2034 (%)
• 6.6 Research Institutes
  • 6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.6.2 Market Share by Region, 2024 & 2034 (%)
• 6.7 Others
  • 6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Synthetic Immunology Market Analysis by Region

• 7.1 Key Findings
• 7.2 Regional Market Size Estimation and Forecast

8 North America Synthetic Immunology Market Analysis

• 8.1 Key Findings
• 8.2 North America Synthetic Immunology Market Attractiveness Index
• 8.3 North America Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 8.4 North America Synthetic Immunology Market Size Estimation and Forecast by Country
• 8.5 North America Synthetic Immunology Market Size Estimation and Forecast by Type
• 8.6 North America Synthetic Immunology Market Size Estimation and Forecast by Application
• 8.7 North America Synthetic Immunology Market Size Estimation and Forecast by End-User
• 8.8 U.S. Synthetic Immunology Market Analysis
• 8.9 Canada Synthetic Immunology Market Analysis

9 Europe Synthetic Immunology Market Analysis

• 9.1 Key Findings
• 9.2 Europe Synthetic Immunology Market Attractiveness Index
• 9.3 Europe Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 9.4 Europe Synthetic Immunology Market Size Estimation and Forecast by Country
• 9.5 Europe Synthetic Immunology Market Size Estimation and Forecast by Type
• 9.6 Europe Synthetic Immunology Market Size Estimation and Forecast by Application
• 9.7 Europe Synthetic Immunology Market Size Estimation and Forecast by End-User
• 9.8 Germany Synthetic Immunology Market Analysis
• 9.9 France Synthetic Immunology Market Analysis
• 9.10 UK Synthetic Immunology Market Analysis
• 9.11 Italy Synthetic Immunology Market Analysis
• 9.12 Spain Synthetic Immunology Market Analysis
• 9.13 Russia Synthetic Immunology Market Analysis
• 9.14 Rest of Europe Synthetic Immunology Market Analysis

10 Asia Pacific Synthetic Immunology Market Analysis

• 10.1 Key Findings
• 10.2 Asia Pacific Synthetic Immunology Market Attractiveness Index
• 10.3 Asia Pacific Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 10.4 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by Country
• 10.5 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by Type
• 10.6 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by Application
• 10.7 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by End-User
• 10.8 Japan Synthetic Immunology Market Analysis
• 10.9 China Synthetic Immunology Market Analysis
• 10.10 India Synthetic Immunology Market Analysis
• 10.11 Australia Synthetic Immunology Market Analysis
• 10.12 South Korea Synthetic Immunology Market Analysis
• 10.13 Singapore Synthetic Immunology Market Analysis
• 10.14 Rest of Asia Pacific Synthetic Immunology Market Analysis

11 Latin America Synthetic Immunology Market Analysis

• 11.1 Key Findings
• 11.2 Latin America Synthetic Immunology Market Attractiveness Index
• 11.3 Latin America Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 11.4 Latin America Synthetic Immunology Market Size Estimation and Forecast by Country
• 11.5 Latin America Synthetic Immunology Market Size Estimation and Forecast by Type
• 11.6 Latin America Synthetic Immunology Market Size Estimation and Forecast by Application
• 11.7 Latin America Synthetic Immunology Market Size Estimation and Forecast by End-User
• 11.8 Brazil Synthetic Immunology Market Analysis
• 11.9 Mexico Synthetic Immunology Market Analysis
• 11.10 Argentina Synthetic Immunology Market Analysis
• 11.11 Colombia Synthetic Immunology Market Analysis
• 11.12 Rest of Latin America Synthetic Immunology Market Analysis

12 MEA Synthetic Immunology Market Analysis

• 12.1 Key Findings
• 12.2 MEA Synthetic Immunology Market Attractiveness Index
• 12.3 MEA Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 12.4 MEA Synthetic Immunology Market Size Estimation and Forecast by Country
• 12.5 MEA Synthetic Immunology Market Size Estimation and Forecast by Type
• 12.6 MEA Synthetic Immunology Market Size Estimation and Forecast by Application
• 12.7 MEA Synthetic Immunology Market Size Estimation and Forecast by End-User
• 12.8 GCC Synthetic Immunology Market Analysis
• 12.9 South Africa Synthetic Immunology Market Analysis
• 12.10 Rest of MEA Synthetic Immunology Market Analysis

13 Company Profiles

• 13.1 Competitive Landscape, 2023
• 13.2 Strategic Outlook
• 13.3 ADC Therapeutics
  • 13.3.1 Company Snapshot
  • 13.3.2 Company Overview
  • 13.3.3 Financial Analysis
    • 13.3.3.1 Net Revenue, 2021-2023
    • 13.3.3.2 R&D Expense, 2018-2023
  • 13.3.4 Product Benchmarking
  • 13.3.5 Strategic Outlook
  • 13.3.6 SWOT Analysis
• 13.4 BioNTech SE
  • 13.4.1 Company Snapshot
  • 13.4.2 Company Overview
  • 13.4.3 Financial Analysis
    • 13.4.3.1 Net Revenue, 2018-2023
    • 13.4.3.2 R&D Expense, 2018-2023
  • 13.4.4 Product Benchmarking
  • 13.4.5 Strategic Outlook
  • 13.4.6 SWOT Analysis
• 13.5 CRISPR Therapeutics AG
  • 13.5.1 Company Snapshot
  • 13.5.2 Company Overview
  • 13.5.3 Financial Analysis
    • 13.5.3.1 Net Revenue, 2018-2023
  • 13.5.4 Product Benchmarking
  • 13.5.5 SWOT Analysis
• 13.6 Editas Medicine, Inc.
  • 13.6.1 Company Snapshot
  • 13.6.2 Company Overview
  • 13.6.3 Financial Analysis
    • 13.6.3.1 Net Revenue, 2018-2023
  • 13.6.4 Product Benchmarking
  • 13.6.5 Strategic Outlook
  • 13.6.6 SWOT Analysis
• 13.7 Synthego
  • 13.7.1 Company Snapshot
  • 13.7.2 Company Overview
  • 13.7.3 Product Benchmarking
  • 13.7.4 SWOT Analysis
• 13.8 GenScript Biotech Corporation
  • 13.8.1 Company Snapshot
  • 13.8.2 Company Overview
  • 13.8.3 Financial Analysis
    • 13.8.3.1 Net Revenue, 2018-2023
  • 13.8.4 Product Benchmarking
  • 13.8.5 Strategic Outlook
  • 13.8.6 SWOT Analysis
• 13.9 Ginkgo Bioworks
  • 13.9.1 Company Snapshot
  • 13.9.2 Company Overview
  • 13.9.3 Product Benchmarking
  • 13.9.4 Strategic Outlook
  • 13.9.5 SWOT Analysis
• 13.10 Inscripta, Inc.
  • 13.10.1 Company Snapshot
  • 13.10.2 Company Overview
  • 13.10.3 Product Benchmarking
  • 13.10.4 Strategic Outlook
  • 13.10.5 SWOT Analysis
• 13.11 Moderna, Inc.
  • 13.11.1 Company Snapshot
  • 13.11.2 Company Overview
  • 13.11.3 Financial Analysis
    • 13.11.3.1 Net Revenue, 2018-2023
    • 13.11.3.2 R&D Expense, 2018-2023
  • 13.11.4 Product Benchmarking
  • 13.11.5 Strategic Outlook
  • 13.11.6 SWOT Analysis
• 13.12 Synlogic Therapeutics
  • 13.12.1 Company Snapshot
  • 13.12.2 Company Overview
  • 13.12.3 Product Benchmarking
  • 13.12.4 SWOT Analysis
• 13.13 Evonetix Ltd.
  • 13.13.1 Company Snapshot
  • 13.13.2 Company Overview
  • 13.13.3 Product Benchmarking
  • 13.13.4 SWOT Analysis
• 13.14 Sherlock Biosciences
  • 13.14.1 Company Snapshot
  • 13.14.2 Company Overview
  • 13.14.3 Product Benchmarking
  • 13.14.4 SWOT Analysis
• 13.15 Mission Therapeutics
  • 13.15.1 Company Snapshot
  • 13.15.2 Company Overview
  • 13.15.3 Product Benchmarking
  • 13.15.4 SWOT Analysis
• 13.16 Camena Bioscience
  • 13.16.1 Company Snapshot
  • 13.16.2 Company Overview
  • 13.16.3 Product Benchmarking
  • 13.16.4 SWOT Analysis
• 13.17 Mammoth Biosciences
  • 13.17.1 Company Snapshot
  • 13.17.2 Company Overview
  • 13.17.3 Product Benchmarking
  • 13.17.4 SWOT Analysis

14 Conclusion and Recommendations

• 14.1 Concluding Remarks from Visiongain
• 14.2 Recommendations for Market Players